TransMed7’s instruments are designed knowing that space occupying lesions are most effectively treated at their earliest stages -- microscopic levels in most cases.  They are also designed with the anticipation of advances in several areas including micro-imaging, genomic profiling, neoadjuvant therapies and earlier detection with increasing access to these important advances for patients around the world.



TransMed7’s solution is to maximize the benefits of these trends with instruments that can be scaled down in caliber to match micro-imaging sizes, streamlined in their profile to gently penetrate and capture the essential information needed for diagnosis to minimize tissue damage, and simplified in their construction to lower costs so that they are affordable in every economy in the world.